Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,196 | Dovepress* | 6,260+ | 163 | 6,423 | |
| PubMed Central* | 1,936 | 453 | 2,389 | ||
| Totals | 8,196 | 616 | 8,812 | ||
| *Since 6 October 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar